Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05704283 · ClinicalTrials.gov registry record · Early Phase 1
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
A Early Phase 1 study of Breast Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05704283: Recruiting Early Phase 1 study of Breast Carcinoma, sponsored by Mayo Clinic.
NCT05704283 is a Early Phase 1 study of Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 55 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05704283, a Early Phase 1 study of Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
Primary Outcome
Will characterize the lymph node as benign or malignant by reviewing images from each imaging technique based on clinical criteria including node size, shape, margin, cortical thickness, stiffness, and vascularity obtained from B-mode, shear wave elastography, and Doppler imaging. Histopathology results will be used as the ground truth to measure sensitivity and specificity of each ultrasound technology for distinguishing between benign and malignant lymph nodes. The overall agreement of the new
Conditions Studied
Interventions
- DEVICE Ultrasound Imaging
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2027-06-01 |
| Phase | Early Phase 1 |
What NCT05704283 shows while recruiting
NCT05704283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Imaging is the first listed.
NCT05704283 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05704283 about?
NCT05704283 is a clinical study titled "3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer". This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
What is the current status of trial NCT05704283?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 55 participants. The study started on 2023-02-14. Estimated completion is 2027-06-01.
What conditions does trial NCT05704283 study?
This clinical trial studies the following conditions: Breast Carcinoma.
What interventions are being tested in trial NCT05704283?
The interventions under investigation include: Ultrasound Imaging (DEVICE).
Who is sponsoring clinical trial NCT05704283?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05704283 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05704283's enrollment target sits among peer trials
55 75th of 106 higher than 32 of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
RECRUITING · Early Phase 1
-
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
ACTIVE NOT RECRUITING · Early Phase 1
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
ACTIVE NOT RECRUITING · Early Phase 1
-
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
COMPLETED · Early Phase 1
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI